Physician profile
Jay Calvert
NPI 1831201193
$40,827.80
in general payments reported to CMS, 2019-2025
13 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $1,384 · 2021: $902 · 2022: $1,456 · 2023: $277 · 2024: $11K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Charitable Contribution: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $2,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Charitable Contribution | $10,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Food and Beverage | $2,402.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $35,609.74 | 2019-2025 | |
| Sientra, INC. | $2,008.17 | 2019-2022 | |
| Abbvie INC. | $954.84 | 2022-2025 | Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $718.37 | 2019-2022 | |
| Polynovo North America LLC | $519.76 | 2023-2024 | Novosorb Btm |
| Motiva USA, LLC | $245.18 | 2024-2025 | |
| Tepha INC | $198.95 | 2019 | |
| Galderma Laboratories, L.P. | $156.39 | 2019-2024 | |
| Rti Surgical, INC | $147.49 | 2025 | |
| Davol INC. | $141.33 | 2023 | Phasix Mesh |
| Integra Lifesciences Corporation | $73.94 | 2019 | |
| Merz North America, INC. | $41.14 | 2019 | |
| Mentor Worldwide LLC | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Calvert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.